AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene FBXO34.
, go to our main page or see our latest news
Homo sapiens gene FBXO34, encoding F-box protein 34.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 267 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in testis (seen 24 times), brain (23), kidney (11), lung (11), placenta (11), colon (10), hippocampus (9), breast carcinoma (7), liver and spleen (7), spleen (7), eye (6), fetal brain (6), neuroblastoma cot 25-normalized (6), pancreas (6), breast (5), carcinoid (5), germinal center B cell (5), head neck (5), prostate (5), uterus (5), whole brain (5), chondrosarcoma (4), purified pancreatic islet (4), senescent fibroblast (4), thymus (4), tongue, tumor tissue (4), trachea (4), 2 pooled tumors (clear cell type) (3), adenocarcinoma (3), human placenta (3), human skeletal muscle (3), nervous normal (3), thalamus (3), bone (2), cell lines (2), cervix (2), colon tumor, RER+ (2), embryonal carcinoma, cell line (2), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (2), liver (2), melanocyte (2), neuroblastoma (2), RPE and choroid (2), serous papillary carcinoma, high grade, 2pooled tumors (2), skin (2), t-lymphocytes (2), tongue (2), total brain (2), adrenal cortex carcinoma, cell line (once), adrenal gland (once), alveolar rhabdomyosarcoma (once), alzheimer cortex (once), amygdala (once), anaplastic oligodendroglioma with 1p/19qloss (once), b-cell, chronic lymphotic leukemia (once), bladder (once), blood vessels - aorta, basilar and artery (once), bone, osteosarcoma (once), cell line (once), choriocarcinoma (once), cochlea (once), colon tumor RER+ (once), colon ins (once), dorsal root ganglia (once), ear (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), embryonic stem cells (once), embryonic stem cells, cell lines H1, H7, andh9 (once), epidermis (once), fetal eye (once), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (once), fetal spleen (once), human chondrosarcoma cell line (once), human embryonic stem cells differentiated toan early endodermal cell type (once), human testis (once), left pelvis (once), lung focal fibrosis (once), marrow (once), melanotic melanoma (once), melanotic melanoma, high MDR (once), muscle (once), nervous tumor (once), neuroepithelial cells (once), normal prostate (once), osteosarcoma, cell line (once), ovary, tumor tissue (once), placenta cot 25-normalized (once), placenta, pre-eclamptic (once), pooled germ cell tumors (once), poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors (once), pre-eclamptic placenta (once), retina (once), retinoblastoma (once), rhabdomyosarcoma (once), small intestine (once), squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) (once), stomach normal (once), testis normal (once), transitional cell papilloma, cell line (once), tumor (once), uterine (once).
267 cDNA clones support the 8 variants of gene FBXO34
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
NM_152231.1 | | .a | 1 to 2830 | 2 to 2831 | exact | RefSeq, | | 2831/2831 (100 %) | 0 diff (100 %id) |
DB098406 | testis | .a | 2 to 587 | 2 to 587 | | tiling clone, capped | | 586/586 (100 %) | 1 diff (99.9 %id) |
DB098752 | testis | .a | 30 to 586 | 2 to 558 | | tiling clone, capped | | 557/557 (100 %) | 0 diff (100 %id) |
AL705341 | human skeletal muscle | .a | 32 to 715 | 1 to 686 | | tiling clone, | | 686/686 (100 %) | 5 diff (99.3 %id) |
AL705342 | human skeletal muscle | .a | 2487 to 3110 | 643 to 20 | | tiling clone, AAA | | 624/629 (99 %) | 0 diff (100 %id) |
NM_017943.3 | | .b | 1 to 3467 | 2 to 3468 | exact | RefSeq, | | 3468/3468 (100 %) | 2 diff (100.0 %id) |
DA228125 | brain | .b | 1 to 551 | 2 to 552 | | tiling clone, capped | | 551/551 (100 %) | 0 diff (100 %id) |
AK092879 | Spleen | .b | 58 to 3463 | 1 to 3405 | S139V S140P W141G D142I I143L ... | available from FLJ, | | 3405/3405 (100 %) | 12 diff (99.7 %id) |
AX747787 | | .b | 58 to 3463 | 1 to 3405 | S139V S140P W141G D142I I143L ... | | | 3405/3405 (100 %) | 12 diff (99.7 %id) |
DA438744 | tongue, tumor tissue | .b | 59 to 649 | 2 to 592 | | capped | | 591/591 (100 %) | 0 diff (100 %id) |
DA934374 | Spleen | .b | 59 to 650 | 2 to 593 | | capped | | 592/592 (100 %) | 2 diff (99.7 %id) |
DA219882 | brain | .b | 65 to 622 | 2 to 559 | | capped | | 558/558 (100 %) | 2 diff (99.7 %id) |
DA021129 | | .b | 67 to 629 | 2 to 564 | | capped | | 563/563 (100 %) | 1 diff (99.9 %id) |
DA237759 | brain | .b | 67 to 617 | 2 to 552 | | capped | | 551/551 (100 %) | 0 diff (100 %id) |
DA329421 | hippocampus | .b | 67 to 624 | 2 to 562 | | capped | | 561/561 (100 %) | 4 diff (99.3 %id) |
DA408965 | thalamus | .b | 67 to 720 | 2 to 655 | | capped | | 654/654 (100 %) | 2 diff (99.7 %id) |
BC109120 | PCR rescued clones | .b | 68 to 3031 | 1 to 2964 | exact | | | 2964/2964 (100 %) | 0 diff (100 %id) |
BC109121 | PCR rescued clones | .b | 68 to 3031 | 1 to 2964 | exact | | | 2964/2964 (100 %) | 0 diff (100 %id) |
DB223296 | trachea | .b | 68 to 578 | 2 to 513 | | capped | | 512/512 (100 %) | 3 diff (99.5 %id) |
DA805312 | brain | .b | 70 to 658 | 2 to 594 | | capped | | 593/593 (100 %) | 9 diff (98.5 %id) |
DA706869 | | .b | 71 to 572 | 2 to 503 | | capped | | 502/502 (100 %) | 2 diff (99.7 %id) |
BF977310 | melanotic melanoma, high MDR, skin | .b | 74 to 693 | 1 to 627 | | | | 627/627 (100 %) | 13 diff (98.0 %id) |
DA656541 | | .b | 78 to 656 | 2 to 580 | | capped | | 579/579 (100 %) | 0 diff (100 %id) |
CN371352 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 82 to 685 | 1 to 603 | | | | 603/603 (100 %) | 2 diff (99.7 %id) |
BI460062 | testis | .b | 82 to 699 | 1 to 609 | | | | 609/609 (100 %) | 13 diff (97.9 %id) |
DA763913 | tongue | .b | 86 to 644 | 2 to 560 | | capped | | 559/559 (100 %) | 0 diff (100 %id) |
DB051696 | testis | .b | 88 to 358 | 2 to 272 | | capped | | 271/271 (100 %) | 2 diff (99.3 %id) |
DB095848 | testis | .b | 88 to 646 | 2 to 560 | | capped | | 559/559 (100 %) | 1 diff (99.9 %id) |
DR004955 | placenta | .b | 89 to 720 | 1 to 632 | | | | 632/633 (99 %) | 10 diff (98.5 %id) |
BI561530 | testis | .b | 93 to 859 | 1 to 785 | | | | 785/974 (80 %) | 19 diff (98.1 %id) |
CR987652 | T-Lymphocytes | .b | 97 to 958 | 1 to 862 | | | | 862/862 (100 %) | 5 diff (99.5 %id) |
CB989098 | Human Placenta, placenta | .b | 98 to 734 | 29 to 670 | | | | 642/884 (72 %) | 17 diff (98.1 %id) |
TI_44350749 | | .b | 98 to 859 | 123 to 902 | | | | 780/1091 (71 %) | 22 diff (98.0 %id) |
BG913502 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 101 to 577 | 1 to 480 | | | | 480/1123 (42 %) | 12 diff (99.0 %id) |
BE279602 | choriocarcinoma, placenta | .b | 103 to 597 | 1 to 495 | | | | 495/495 (100 %) | 1 diff (99.8 %id) |
BI545800 | brain, hippocampus | .b | 113 to 903 | 1 to 806 | | | | 806/920 (87 %) | 31 diff (96.7 %id) |
DA406105 | thalamus | .b | 117 to 723 | 2 to 608 | | capped | | 607/607 (100 %) | 1 diff (99.9 %id) |
DA408393 | thalamus | .b | 117 to 666 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DA457365 | tongue, tumor tissue | .b | 117 to 685 | 2 to 570 | | capped | | 569/569 (100 %) | 0 diff (100 %id) |
DB051559 | testis | .b | 117 to 671 | 2 to 556 | | capped | | 555/555 (100 %) | 0 diff (100 %id) |
DB239249 | trachea | .b | 117 to 703 | 2 to 587 | | capped | | 586/595 (98 %) | 1 diff (99.9 %id) |
TI_44165808 | | .b | 118 to 903 | 91 to 891 | | | | 801/1005 (79 %) | 34 diff (96.7 %id) |
DA450246 | tongue, tumor tissue | .b | 119 to 668 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DA456001 | tongue, tumor tissue | .b | 119 to 676 | 2 to 559 | | capped | | 558/558 (100 %) | 0 diff (100 %id) |
DB083890 | testis | .b | 119 to 665 | 2 to 548 | | capped | | 547/547 (100 %) | 0 diff (100 %id) |
DB481192 | hippocampus | .b | 122 to 861 | 1 to 740 | | | | 740/740 (100 %) | 6 diff (99.2 %id) |
DB468154 | hippocampus | .b | 126 to 852 | 1 to 725 | | | | 725/726 (99 %) | 12 diff (98.4 %id) |
BF304039 | muscle, rhabdomyosarcoma | .b | 127 to 702 | 1 to 574 | | | | 574/904 (63 %) | 24 diff (97.4 %id) |
DB229533 | trachea | .b | 128 to 716 | 2 to 590 | | capped | | 589/589 (100 %) | 0 diff (100 %id) |
DR157217 | human embryonic stem cells differentiated toan early endodermal cell type | .b | 129 to 860 | 1 to 732 | | | | 732/732 (100 %) | 0 diff (100 %id) |
BG719522 | testis | .b | 132 to 838 | 1 to 711 | | | | 711/717 (99 %) | 10 diff (98.7 %id) |
CB990204 | Human Placenta, placenta | .b | 138 to 858 | 27 to 757 | | | | 731/777 (94 %) | 20 diff (97.5 %id) |
CF994289 | Human Placenta, placenta | .b | 138 to 789 | 27 to 686 | | | | 660/843 (78 %) | 19 diff (97.8 %id) |
DA810662 | brain | .b | 142 to 701 | 2 to 561 | | capped | | 560/560 (100 %) | 0 diff (100 %id) |
DA810728 | brain | .b | 143 to 688 | 2 to 547 | | capped | | 546/546 (100 %) | 1 diff (99.9 %id) |
BX248268 | neuroblastoma | .b | 148 to 3185 | 1 to 3038 | exact | tiling clone, | | 3038/3038 (100 %) | 0 diff (100 %id) |
BX354141 | Neuroblastoma Cot 25-normalized | .b | 149 to 1098 | 1 to 944 | | | | 944/948 (99 %) | 7 diff (99.3 %id) |
DB636366 | testis | .b | 150 to 807 | 1 to 658 | | | | 658/658 (100 %) | 2 diff (99.7 %id) |
CN371350 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 152 to 795 | 1 to 645 | | | | 645/645 (100 %) | 1 diff (99.9 %id) |
BC095482 | Placenta, pre-eclamptic | .b | 195 to 3462 | 1 to 3267 | I470N L533P | AAA | | 3267/3267 (100 %) | 5 diff (99.9 %id) |
BX956902 | | .b | 233 to 763 | 27 to 562 | | | | 536/562 (95 %) | 6 diff (99.0 %id) |
CB992783 | placenta, pre-eclamptic placenta | .b | 233 to 959 | 66 to 797 | | | | 732/800 (91 %) | 7 diff (99.2 %id) |
AA699458 | liver and spleen | .b | 284 to 688 | 405 to 1 | | | | 405/457 (88 %) | 0 diff (100 %id) |
AI074575 | liver and spleen | .b | 284 to 688 | 405 to 1 | | | | 405/459 (88 %) | 0 diff (100 %id) |
R14855 | liver and spleen | .b | 286 to 688 | 420 to 1 | | | | 420/423 (99 %) | 12 diff (97.2 %id) |
DA906869 | | .b | 353 to 936 | 2 to 585 | | capped | | 584/584 (100 %) | 0 diff (100 %id) |
AA209242 | | .b | 387 to 856 | 1 to 472 | | | | 472/472 (100 %) | 17 diff (96.4 %id) |
BG402733 | bladder, transitional cell papilloma, cell line | .b | 428 to 1139 | 13 to 721 | | | | 709/723 (98 %) | 7 diff (99.1 %id) |
BX641609 | | .b | 431 to 891 | 1 to 461 | | | | 461/461 (100 %) | 0 diff (100 %id) |
DB148693 | thymus | .b | 456 to 993 | 2 to 539 | | capped | | 538/538 (100 %) | 1 diff (99.9 %id) |
AL704720 | human skeletal muscle | .b | 641 to 855 | 1 to 215 | | | | 215/215 (100 %) | 6 diff (97.3 %id) |
BG257650 | embryonal carcinoma, cell line, testis | .b | 641 to 1265 | 100 to 727 | | | | 628/730 (86 %) | 6 diff (99.2 %id) |
DA493409 | brain | .b | 713 to 1264 | 2 to 553 | | capped | | 552/552 (100 %) | 2 diff (99.7 %id) |
DA510332 | brain | .b | 714 to 1284 | 2 to 572 | | capped | | 571/571 (100 %) | 0 diff (100 %id) |
CN371351 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 737 to 1108 | 1 to 372 | | | | 372/372 (100 %) | 1 diff (99.8 %id) |
BX388543 | Neuroblastoma Cot 25-normalized | .b | 830 to 1729 | 1 to 889 | | | | 889/889 (100 %) | 25 diff (97.2 %id) |
DA205166 | brain | .b | 857 to 1389 | 2 to 534 | | capped | | 533/533 (100 %) | 1 diff (99.9 %id) |
AK092873 | Spleen | .b | 868 to 3217 | 1 to 2352 | | available from FLJ, | | 2352/2352 (100 %) | 3 diff (99.9 %id) |
AX747783 | | .b | 868 to 3217 | 1 to 2352 | | | | 2352/2352 (100 %) | 3 diff (99.9 %id) |
DA934043 | Spleen | .b | 869 to 1430 | 2 to 563 | | capped | | 562/564 (99 %) | 1 diff (99.9 %id) |
BX326216 | Neuroblastoma Cot 25-normalized | .b | 942 to 1789 | 1 to 858 | | | | 858/974 (88 %) | 26 diff (97.4 %id) |
DA143639 | alzheimer cortex | .b | 951 to 1492 | 2 to 544 | | capped | | 543/543 (100 %) | 1 diff (99.9 %id) |
DB454004 | testis | .b | 953 to 1446 | 1 to 494 | | | | 494/494 (100 %) | 0 diff (100 %id) |
DB454005 | testis | .b | 953 to 1441 | 1 to 489 | | | | 489/489 (100 %) | 0 diff (100 %id) |
DB024218 | testis | .b | 959 to 1515 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DB024261 | testis | .b | 959 to 1511 | 2 to 554 | | capped | | 553/553 (100 %) | 0 diff (100 %id) |
CR622495 | fetal brain | .b | 961 to 3460 | 1 to 2500 | | | | 2500/2500 (100 %) | 0 diff (100 %id) |
BX441922 | brain, fetal brain | .b | 961 to 1949 | 1 to 983 | | | | 983/986 (99 %) | 12 diff (98.8 %id) |
DN992458 | brain, whole brain | .b | 962 to 1622 | 9 to 669 | | | | 661/669 (98 %) | 6 diff (99.2 %id) |
BF950713 | nervous_normal | .b | 967 to 1321 | 359 to 3 | | | | 357/368 (97 %) | 0 diff (100 %id) |
BX451361 | neuroblastoma | .b | 1003 to 1534 | 42 to 584 | | AAA | | 543/647 (83 %) | 25 diff (96.2 %id) |
BG958116 | colon | .b | 1044 to 1448 | 20 to 423 | | | | 404/423 (95 %) | 8 diff (98.2 %id) |
R25686 | whole brain | .b | 1153 to 1491 | 1 to 345 | | | | 345/345 (100 %) | 9 diff (97.4 %id) |
EC540087 | Prostate | .b | 1165 to 1261 | 95 to 1 | | | | 95/95 (100 %) | 2 diff (97.9 %id) |
EC540187 | Prostate | .b | 1165 to 1261 | 97 to 1 | | | | 97/97 (100 %) | 0 diff (100 %id) |
DB203223 | trachea | .b | 1174 to 1738 | 2 to 565 | | capped | | 564/564 (100 %) | 1 diff (99.9 %id) |
DA515067 | brain | .b | 1195 to 1751 | 2 to 559 | | capped | | 558/558 (100 %) | 1 diff (99.9 %id) |
BC063526 | Bone, osteosarcoma | .b | 1256 to 3217 | 1 to 1963 | | available from MGC, AAA | | 1963/1963 (100 %) | 1 diff (100.0 %id) |
BG111045 | Bone, osteosarcoma, cell line | .b | 1257 to 1998 | 1 to 726 | | available from MGC, | | 726/917 (79 %) | 35 diff (96.2 %id) |
DB079897 | testis | .b | 1283 to 1846 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DB192245 | ovary, tumor tissue | .b | 1385 to 1930 | 2 to 548 | | capped | | 547/547 (100 %) | 1 diff (99.9 %id) |
T57448 | fetal spleen, Spleen | .b | 1419 to 1811 | 1 to 407 | | | | 407/409 (99 %) | 20 diff (95.2 %id) |
R60112 | whole brain | .b | 1446 to 1966 | 1 to 532 | | | | 532/532 (100 %) | 17 diff (96.9 %id) |
DA763300 | tongue | .b | 1450 to 2008 | 2 to 560 | | capped | | 559/559 (100 %) | 0 diff (100 %id) |
AK000732 | | .b | 1457 to 3463 | 1 to 2006 | | available from FLJ, | | 2006/2006 (100 %) | 6 diff (99.8 %id) |
AK225367 | Liver | .b | 1457 to 2551 | 1 to 1095 | | | | 1095/1095 (100 %) | 2 diff (99.9 %id) |
BP241097 | Liver | .b | 1457 to 2023 | 1 to 567 | | | | 567/567 (100 %) | 3 diff (99.5 %id) |
CR457249 | | .b | 1463 to 2380 | 1 to 918 | | | | 918/918 (100 %) | 3 diff (99.7 %id) |
BQ880177 | dorsal root ganglia | .b | 1478 to 2400 | 1 to 927 | | | | 927/927 (100 %) | 22 diff (97.7 %id) |
AW863777 | stomach_normal | .b | 1487 to 1931 | 451 to 6 | | | | 446/465 (95 %) | 0 diff (100 %id) |
BQ306305 | breast | .b | 1490 to 2086 | 1 to 596 | | | | 596/596 (100 %) | 13 diff (97.9 %id) |
BQ306647 | breast | .b | 1490 to 1843 | 1 to 354 | | | | 354/354 (100 %) | 11 diff (96.9 %id) |
BQ306600 | breast | .b | 1494 to 2133 | 6 to 644 | | | | 639/644 (99 %) | 6 diff (99.1 %id) |
BQ308172 | breast | .b | 1494 to 2155 | 664 to 10 | | | | 655/670 (97 %) | 0 diff (100 %id) |
BP312220 | brain | .b | 1506 to 2088 | 1 to 582 | | | | 582/582 (100 %) | 4 diff (99.4 %id) |
DA172610 | amygdala | .b | 1543 to 2125 | 2 to 584 | | capped | | 583/583 (100 %) | 0 diff (100 %id) |
BX368296 | Neuroblastoma Cot 25-normalized | .b | 1559 to 2399 | 839 to 1 | | | | 839/931 (90 %) | 29 diff (96.9 %id) |
CN427708 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 1580 to 1922 | 1 to 344 | | | | 344/344 (100 %) | 2 diff (99.5 %id) |
BQ306534 | breast | .b | 1586 to 2165 | 585 to 7 | | | | 579/585 (98 %) | 0 diff (100 %id) |
CU448017 | epidermis | .b | 1633 to 2378 | 1 to 747 | | | | 747/747 (100 %) | 13 diff (98.3 %id) |
CB127325 | cervix, Uterine | .b | 1656 to 1792 | 1 to 137 | | | | 137/137 (100 %) | 0 diff (100 %id) |
BX367997 | Neuroblastoma Cot 25-normalized | .b | 1669 to 2526 | 855 to 1 | | | | 855/855 (100 %) | 8 diff (99.1 %id) |
BX452116 | brain, fetal brain | .b | 1710 to 2281 | 1 to 575 | | | | 575/635 (90 %) | 22 diff (96.6 %id) |
BX452098 | brain, fetal brain | .b | 1714 to 2682 | 1 to 959 | | | | 959/959 (100 %) | 24 diff (97.5 %id) |
BX408814 | brain, fetal brain | .b | 1715 to 2599 | 1 to 887 | | | | 887/887 (100 %) | 6 diff (99.4 %id) |
CD520728 | pooled | .b | 1729 to 2500 | 1 to 782 | | | | 782/783 (99 %) | 21 diff (97.4 %id) |
F11342 | brain, total brain | .b | 1743 to 2112 | 1 to 370 | | | | 370/370 (100 %) | 2 diff (99.5 %id) |
AA382602 | testis | .b | 1777 to 2033 | 1 to 257 | | | | 257/257 (100 %) | 2 diff (99.3 %id) |
BI488434 | brain | .b | 1800 to 2532 | 1 to 731 | | | | 731/731 (100 %) | 2 diff (99.8 %id) |
TI_45378860 | | .b | 1800 to 2531 | 63 to 793 | | | | 731/793 (92 %) | 2 diff (99.8 %id) |
BG611980 | adenocarcinoma, Prostate | .b | 1872 to 2480 | 1 to 610 | | | | 610/610 (100 %) | 1 diff (99.9 %id) |
BF791739 | adrenal cortex carcinoma, cell line, adrenal gland | .b | 1909 to 2664 | 1 to 759 | | | | 759/1009 (75 %) | 16 diff (98.5 %id) |
BF954872 | nervous_normal | .b | 1911 to 2205 | 1 to 296 | | | | 296/296 (100 %) | 9 diff (97.0 %id) |
BQ340030 | nervous_normal | .b | 1914 to 2209 | 1 to 295 | | | | 295/295 (100 %) | 8 diff (97.3 %id) |
BI018106 | marrow | .b | 1918 to 2298 | 1 to 380 | | | | 380/380 (100 %) | 6 diff (98.5 %id) |
BF760323 | colon | .b | 1938 to 2293 | 1 to 355 | | | | 355/355 (100 %) | 2 diff (99.5 %id) |
BQ356278 | head_neck | .b | 1940 to 2279 | 1 to 342 | | | | 342/386 (88 %) | 13 diff (96.7 %id) |
DB517102 | testis | .b | 1942 to 2567 | 1 to 626 | | AAA | Submitted on the opposite strand | 626/626 (100 %) | 0 diff (100 %id) |
AA360738 | | .b | 1947 to 2213 | 1 to 267 | | | | 267/267 (100 %) | 0 diff (100 %id) |
AW959016 | | .b | 1948 to 2476 | 1 to 525 | | | | 525/529 (99 %) | 13 diff (97.6 %id) |
DB465293 | hippocampus | .b | 2006 to 2440 | 1 to 435 | | | | 435/435 (100 %) | 0 diff (100 %id) |
T94185 | lung | .b | 2021 to 2333 | 1 to 318 | | | | 318/322 (98 %) | 12 diff (96.3 %id) |
T98242 | lung | .b | 2021 to 2190 | 1 to 170 | | | | 170/170 (100 %) | 0 diff (100 %id) |
AA563984 | colon, tumor | .b | 2080 to 2558 | 1 to 477 | | | Submitted on the opposite strand | 477/477 (100 %) | 7 diff (98.6 %id) |
BE218444 | carcinoid, lung | .b | 2085 to 2545 | 461 to 1 | | | | 461/461 (100 %) | 0 diff (100 %id) |
BG957605 | colon | .b | 2101 to 2551 | 1 to 451 | | | | 451/451 (100 %) | 5 diff (98.9 %id) |
BG957588 | colon | .b | 2104 to 2551 | 18 to 458 | | | | 441/458 (96 %) | 6 diff (98.7 %id) |
T91448 | liver and spleen | .b | 2127 to 2427 | 1 to 305 | | | | 305/309 (98 %) | 7 diff (97.8 %id) |
T84160 | liver and spleen | .b | 2131 to 2535 | 1 to 411 | | | | 411/463 (88 %) | 26 diff (94.4 %id) |
AA883087 | pooled | .b | 2147 to 2571 | 427 to 5 | | | | 423/427 (99 %) | 0 diff (100 %id) |
AA300867 | testis | .b | 2185 to 2373 | 1 to 189 | | | | 189/189 (100 %) | 2 diff (99.0 %id) |
BX332741 | Neuroblastoma Cot 25-normalized | .b | 2206 to 3185 | 972 to 1 | | | | 972/973 (99 %) | 11 diff (98.9 %id) |
AA897743 | pooled | .b | 2222 to 2571 | 354 to 5 | | | | 350/354 (98 %) | 0 diff (100 %id) |
BQ346418 | nervous_tumor | .b | 2225 to 2557 | 1 to 333 | | | | 333/340 (97 %) | 3 diff (99.2 %id) |
AI309778 | 2 pooled tumors (clear cell type), Kidney | .b | 2307 to 2556 | 116 to 366 | | | Submitted on the opposite strand | 251/366 (68 %) | 6 diff (98.4 %id) |
AA383534 | testis | .b | 2323 to 2519 | 1 to 196 | | | | 196/196 (100 %) | 2 diff (99.0 %id) |
AA296534 | uterus | .b | 2332 to 2602 | 1 to 279 | | | | 279/279 (100 %) | 8 diff (97.2 %id) |
AW959754 | | .b | 2333 to 2852 | 1 to 514 | | | | 514/514 (100 %) | 29 diff (94.4 %id) |
AW959759 | | .b | 2333 to 2826 | 1 to 493 | | | | 493/493 (100 %) | 4 diff (99.2 %id) |
CV421992 | head_neck | .b | 2385 to 2606 | 232 to 8 | | | Submitted on the opposite strand | 225/232 (96 %) | 0 diff (100 %id) |
TI_151789400 | | .b | 2390 to 3247 | 78 to 924 | | | | 847/945 (89 %) | 29 diff (97.0 %id) |
BM930812 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2391 to 3070 | 1 to 680 | | | | 680/680 (100 %) | 2 diff (99.8 %id) |
BQ440751 | melanotic melanoma, skin | .b | 2406 to 3223 | 1 to 820 | | | | 820/833 (98 %) | 14 diff (98.4 %id) |
BM691174 | eye, RPE and Choroid | .b | 2406 to 3073 | 1 to 668 | | | | 668/668 (100 %) | 8 diff (98.9 %id) |
FN166311 | breast carcinoma | .b | 2416 to 2508 | 1 to 93 | | | | 93/93 (100 %) | 0 diff (100 %id) |
CB998470 | Blood vessels - aorta, basilar and artery | .b | 2430 to 3065 | 1 to 644 | | | | 644/761 (84 %) | 19 diff (97.6 %id) |
BF813803 | colon_ins | .b | 2518 to 3113 | 618 to 25 | | | Submitted on the opposite strand | 594/622 (95 %) | 0 diff (100 %id) |
W23978 | senescent fibroblast | .b | 2531 to 2967 | 1 to 448 | | | | 448/451 (99 %) | 13 diff (97.2 %id) |
BX103468 | senescent fibroblast | .b | 2533 to 3220 | 1 to 690 | | | | 690/690 (100 %) | 3 diff (99.6 %id) |
TI_154059572 | | .b | 2557 to 3463 | 973 to 84 | | AAA | | 890/985 (90 %) | 27 diff (97.3 %id) |
BU950605 | Pancreas, Purified pancreatic islet | .b | 2581 to 3173 | 1 to 592 | | | | 592/592 (100 %) | 3 diff (99.5 %id) |
BQ004530 | Chondrosarcoma, Left Pelvis | .b | 2609 to 3217 | 627 to 19 | | AAA | | 609/609 (100 %) | 0 diff (100 %id) |
BQ232833 | embryonal carcinoma, cell line, testis | .b | 2611 to 2918 | 1 to 308 | | | | 308/314 (98 %) | 1 diff (99.7 %id) |
CK826476 | Pancreas, Purified pancreatic islet | .b | 2627 to 3003 | 1 to 377 | | | Submitted on the opposite strand | 377/377 (100 %) | 0 diff (100 %id) |
CR622458 | thymus | .b | 2658 to 3461 | 1 to 804 | | | | 804/804 (100 %) | 0 diff (100 %id) |
BX456939 | thymus | .b | 2658 to 3094 | 1 to 438 | | fully sequenced, | | 438/438 (100 %) | 2 diff (99.6 %id) |
BX344966.
matches multiple genes | placenta, Placenta Cot 25-normalized | .b | 2658 to 2951 | 1 to 293 | | | also hits gene FLJ45248 | 293/293 (100 %) | 7 diff (97.7 %id) |
H95526 | eye, retina | .b | 2665 to 2999 | 1 to 339 | | | | 339/346 (97 %) | 4 diff (98.9 %id) |
DB332698 | Spleen | .b | 2670 to 3217 | 552 to 1 | | | | 552/552 (100 %) | 7 diff (98.8 %id) |
BE154253 | head_neck | .b | 2680 to 3131 | 1 to 448 | | | | 448/482 (92 %) | 6 diff (98.8 %id) |
BX449996 | brain, fetal brain | .b | 2680 to 3436 | 759 to 1 | | | | 759/869 (87 %) | 10 diff (98.9 %id) |
BU950311 | Pancreas, Purified pancreatic islet | .b | 2685 to 3218 | 533 to 1 | | | | 533/533 (100 %) | 1 diff (99.9 %id) |
CA428544 | cell lines, Chondrosarcoma | .b | 2692 to 3463 | 782 to 19 | | AAA | | 764/765 (99 %) | 8 diff (99.0 %id) |
CK826477 | Pancreas, Purified pancreatic islet | .b | 2699 to 3212 | 513 to 1 | | | Submitted on the opposite strand | 513/513 (100 %) | 7 diff (98.7 %id) |
DB550009 | hippocampus | .b | 2731 to 3462 | 1 to 730 | | | Submitted on the opposite strand | 730/730 (100 %) | 4 diff (99.5 %id) |
BM684663 | eye, fetal eye | .b | 2734 to 3463 | 745 to 19 | | AAA | | 727/727 (100 %) | 4 diff (99.5 %id) |
FN133240 | breast carcinoma | .b | 2735 to 2846 | 110 to 2 | | | Submitted on the opposite strand | 109/111 (98 %) | 0 diff (100 %id) |
DB535349 | hippocampus | .b | 2740 to 3463 | 1 to 720 | | | Submitted on the opposite strand | 720/720 (100 %) | 6 diff (99.2 %id) |
BP421526 | small intestine | .b | 2749 to 3280 | 1 to 531 | | | Submitted on the opposite strand | 531/531 (100 %) | 1 diff (99.9 %id) |
AI862171 | | .b | 2754 to 3217 | 475 to 13 | | AAA | | 463/463 (100 %) | 2 diff (99.6 %id) |
CA419785 | Bone, Human Chondrosarcoma Cell Line | .b | 2759 to 3463 | 724 to 19 | | AAA | | 706/706 (100 %) | 1 diff (99.9 %id) |
BU618602 | Cell Line, Chondrosarcoma | .b | 2759 to 3463 | 724 to 19 | | AAA | | 706/706 (100 %) | 2 diff (99.8 %id) |
BQ016963 | lung, Lung Focal Fibrosis | .b | 2760 to 3408 | 692 to 46 | | AAA | | 647/674 (95 %) | 0 diff (100 %id) |
FN124606 | breast carcinoma | .b | 2765 to 2859 | 1 to 95 | | | | 95/99 (95 %) | 1 diff (99.0 %id) |
AW340337 | pooled | .b | 2770 to 3221 | 453 to 2 | | | | 452/453 (99 %) | 0 diff (100 %id) |
BU631132 | cell lines, Chondrosarcoma | .b | 2837 to 3463 | 646 to 19 | | AAA | | 628/628 (100 %) | 3 diff (99.6 %id) |
AW003113 | pooled germ cell tumors | .b | 2864 to 3463 | 599 to 1 | | | | 599/599 (100 %) | 2 diff (99.7 %id) |
AI739045 | colon, colon tumor, RER+ | .b | 2866 to 3464 | 599 to 1 | | | | 599/599 (100 %) | 2 diff (99.7 %id) |
C75136 | | .b | 2897 to 3470 | 573 to 2 | | | | 572/575 (99 %) | 0 diff (100 %id) |
CD522769 | pooled | .b | 2901 to 3465 | 1 to 564 | | | | 564/565 (99 %) | 6 diff (99.0 %id) |
DB332720 | Spleen | .b | 2913 to 3463 | 551 to 1 | | | | 551/551 (100 %) | 4 diff (99.3 %id) |
AI566760 | Kidney | .b | 2915 to 3465 | 552 to 1 | | | | 552/552 (100 %) | 2 diff (99.7 %id) |
R45655 | whole brain | .b | 2922 to 3266 | 367 to 16 | | | | 352/368 (95 %) | 0 diff (100 %id) |
BE844078 | testis_normal | .b | 2928 to 3220 | 1 to 294 | | | | 294/304 (96 %) | 6 diff (98.1 %id) |
BE538378 | cervix | .b | 2936 to 3457 | 1 to 518 | | | | 518/520 (99 %) | 13 diff (97.5 %id) |
BE857693 | Prostate | .b | 2937 to 3463 | 526 to 1 | | | | 526/526 (100 %) | 1 diff (99.9 %id) |
BF433089 | carcinoid, lung | .b | 2949 to 3465 | 518 to 2 | | | | 517/518 (99 %) | 0 diff (100 %id) |
AW317061 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 2967 to 3463 | 497 to 1 | | | | 497/497 (100 %) | 0 diff (100 %id) |
AW614098 | Kidney | .b | 2972 to 3465 | 496 to 4 | | | | 493/496 (99 %) | 0 diff (100 %id) |
AI911690 | adenocarcinoma, Pancreas | .b | 2976 to 3465 | 492 to 3 | | | | 490/492 (99 %) | 0 diff (100 %id) |
AW082259 | pooled | .b | 2976 to 3465 | 491 to 2 | | | | 490/491 (99 %) | 0 diff (100 %id) |
AI095936 | uterus | .b | 2977 to 3463 | 499 to 14 | | AAA | | 486/486 (100 %) | 2 diff (99.6 %id) |
AI632682 | Kidney | .b | 2986 to 3465 | 481 to 3 | | | | 479/481 (99 %) | 0 diff (100 %id) |
AW338449 | adenocarcinoma, Pancreas | .b | 2992 to 3464 | 472 to 1 | | | | 472/472 (100 %) | 1 diff (99.8 %id) |
AI149486 | placenta | .b | 3001 to 3464 | 464 to 1 | | | | 464/464 (100 %) | 4 diff (99.2 %id) |
BQ012694 | placenta | .b | 3004 to 3463 | 477 to 19 | | AAA | | 459/459 (100 %) | 2 diff (99.6 %id) |
AI859752 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 3007 to 3464 | 458 to 1 | | | | 458/458 (100 %) | 2 diff (99.6 %id) |
AI380853 | B-cell, chronic lymphotic leukemia | .b | 3009 to 3463 | 453 to 1 | | | | 453/453 (100 %) | 4 diff (99.2 %id) |
AI128339 | placenta | .b | 3011 to 3464 | 454 to 1 | | | | 454/454 (100 %) | 2 diff (99.6 %id) |
FN056317 | breast carcinoma | .b | 3019 to 3104 | 1 to 86 | | | | 86/87 (98 %) | 1 diff (98.9 %id) |
AI168072 | senescent fibroblast | .b | 3024 to 3463 | 451 to 11 | | AAA | | 441/441 (100 %) | 1 diff (99.8 %id) |
AI831679 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .b | 3028 to 3463 | 446 to 12 | | AAA | | 435/435 (100 %) | 3 diff (99.4 %id) |
N21428 | melanocyte | .b | 3031 to 3463 | 435 to 1 | | | | 435/435 (100 %) | 14 diff (96.8 %id) |
AI928400 | Kidney | .b | 3036 to 3464 | 428 to 1 | | | | 428/428 (100 %) | 2 diff (99.6 %id) |
AI935685 | Kidney | .b | 3036 to 3464 | 429 to 1 | | | | 429/429 (100 %) | 11 diff (97.5 %id) |
AW292292 | | .b | 3036 to 3463 | 444 to 18 | | AAA | | 427/427 (100 %) | 1 diff (99.8 %id) |
BE716290 | head_neck | .b | 3038 to 3477 | 1 to 445 | | | | 445/445 (100 %) | 25 diff (94.4 %id) |
DB531852 | hippocampus | .b | 3038 to 3468 | 1 to 430 | | | Submitted on the opposite strand | 430/430 (100 %) | 3 diff (99.4 %id) |
T94100 | lung | .b | 3039 to 3430 | 394 to 1 | | | | 394/398 (98 %) | 2 diff (99.5 %id) |
AI826519 | normal prostate, Prostate | .b | 3039 to 3463 | 425 to 1 | | | | 425/425 (100 %) | 4 diff (99.1 %id) |
AA765550 | germinal center B cell | .b | 3041 to 3470 | 432 to 3 | | | | 430/432 (99 %) | 0 diff (100 %id) |
DB509492 | testis | .b | 3042 to 3465 | 1 to 425 | | | Submitted on the opposite strand | 425/430 (98 %) | 5 diff (98.9 %id) |
AI634830 | Kidney | .b | 3048 to 3463 | 416 to 1 | | | | 416/416 (100 %) | 0 diff (100 %id) |
AI767450 | Kidney | .b | 3048 to 3463 | 416 to 1 | | | | 416/416 (100 %) | 0 diff (100 %id) |
BF739867 | Kidney | .b | 3048 to 3463 | 416 to 1 | | | | 416/416 (100 %) | 0 diff (100 %id) |
DB519449 | testis | .b | 3049 to 3468 | 1 to 419 | | tiling clone, | Submitted on the opposite strand | 419/419 (100 %) | 1 diff (99.8 %id) |
BX456938 | thymus | .b | 3064 to 3438 | 374 to 1 | | fully sequenced, | | 374/374 (100 %) | 1 diff (99.8 %id) |
AA219655 | brain, neuroepithelial cells | .b | 3064 to 3464 | 402 to 1 | | | | 402/413 (97 %) | 4 diff (99.1 %id) |
AA968813 | carcinoid, lung | .b | 3064 to 3465 | 403 to 2 | | | | 402/403 (99 %) | 0 diff (100 %id) |
AI220601 | pooled | .b | 3067 to 3465 | 399 to 2 | | | | 398/399 (99 %) | 0 diff (100 %id) |
AA808651 | germinal center B cell | .b | 3076 to 3463 | 398 to 11 | | AAA | | 388/388 (100 %) | 0 diff (100 %id) |
AI796364 | 2 pooled tumors (clear cell type), Kidney | .b | 3093 to 3465 | 375 to 3 | | | | 373/375 (99 %) | 0 diff (100 %id) |
AI375725 | | .b | 3095 to 3470 | 377 to 3 | | | | 375/377 (99 %) | 0 diff (100 %id) |
AI916120 | colon, colon tumor, RER+ | .b | 3095 to 3463 | 367 to 1 | | | | 367/367 (100 %) | 2 diff (99.5 %id) |
AI873262 | pooled | .b | 3096 to 3465 | 370 to 1 | | | | 370/370 (100 %) | 1 diff (99.8 %id) |
N24607 | melanocyte | .b | 3108 to 3457 | 358 to 7 | | | | 352/359 (98 %) | 0 diff (100 %id) |
AI189470 | placenta | .b | 3112 to 3463 | 363 to 13 | | AAA | | 351/351 (100 %) | 1 diff (99.8 %id) |
AI702089 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .b | 3115 to 3463 | 364 to 15 | | AAA | | 350/350 (100 %) | 4 diff (98.9 %id) |
AI309203 | 2 pooled tumors (clear cell type), Kidney | .b | 3122 to 3465 | 344 to 2 | | | | 343/344 (99 %) | 0 diff (100 %id) |
AI796917 | carcinoid, lung | .b | 3124 to 3463 | 350 to 11 | | AAA | | 340/341 (99 %) | 3 diff (99.2 %id) |
AA912722 | pooled | .b | 3132 to 3465 | 334 to 1 | | | | 334/334 (100 %) | 0 diff (100 %id) |
R60050 | whole brain | .b | 3140 to 3464 | 335 to 11 | | AAA | | 325/328 (99 %) | 0 diff (100 %id) |
FN093074 | breast carcinoma | .b | 3143 to 3246 | 1 to 106 | | | | 106/106 (100 %) | 2 diff (98.2 %id) |
T85094 | liver and spleen | .b | 3144 to 3465 | 322 to 1 | | | | 322/322 (100 %) | 1 diff (99.7 %id) |
BU726520 | eye, RPE and Choroid | .b | 3144 to 3464 | 338 to 18 | | AAA | | 321/321 (100 %) | 3 diff (99.1 %id) |
AA313288 | colon | .b | 3146 to 3463 | 319 to 1 | | | Submitted on the opposite strand | 319/319 (100 %) | 1 diff (99.7 %id) |
AA729278 | alveolar rhabdomyosarcoma | .b | 3154 to 3463 | 9 to 318 | | AAA | | 310/318 (97 %) | 6 diff (98.2 %id) |
F09002 | brain, total brain | .b | 3160 to 3463 | 304 to 1 | | | | 304/304 (100 %) | 0 diff (100 %id) |
T98243 | lung | .b | 3169 to 3442 | 279 to 1 | | | | 279/304 (91 %) | 7 diff (97.7 %id) |
AI914196 | carcinoid, lung | .b | 3200 to 3465 | 267 to 2 | | | | 266/267 (99 %) | 0 diff (100 %id) |
AJ278584 | colon | .b | 3201 to 3463 | 1 to 263 | | | | 263/263 (100 %) | 0 diff (100 %id) |
N71902 | cochlea, ear | .b | 3220 to 3463 | 247 to 1 | | | | 247/247 (100 %) | 3 diff (98.8 %id) |
N99143 | senescent fibroblast | .b | 3239 to 3465 | 231 to 5 | | | | 227/232 (97 %) | 0 diff (100 %id) |
AA211937 | | .b | 3239 to 3470 | 239 to 9 | | | | 231/239 (96 %) | 0 diff (100 %id) |
T91361 | liver and spleen | .b | 3252 to 3431 | 180 to 1 | | | | 180/180 (100 %) | 2 diff (98.9 %id) |
BE715549 | head_neck | .b | 3268 to 3406 | 155 to 19 | | | | 137/160 (85 %) | 0 diff (100 %id) |
FN054964 | breast carcinoma | .b | 3309 to 3414 | 1 to 106 | | | | 106/106 (100 %) | 0 diff (100 %id) |
FN123200 | breast carcinoma | .b | 3322 to 3447 | 1 to 128 | | | | 128/130 (98 %) | 4 diff (97.0 %id) |
AA809751 | germinal center B cell | .b | 3323 to 3470 | 150 to 3 | | | | 148/154 (96 %) | 0 diff (100 %id) |
AA579708 | colon, colon tumor RER+ | .b | 3350 to 3465 | 117 to 2 | | | | 116/117 (99 %) | 0 diff (100 %id) |
BM889543 | | .b | 3364 to 3460 | 101 to 5 | | | | 97/101 (96 %) | 0 diff (100 %id) |
BM873519 | | .b | 3386 to 3460 | 1 to 75 | | | | 75/78 (96 %) | 1 diff (98.8 %id) |
DA296712 | hippocampus | .c | 1 to 576 | 2 to 577 | | tiling clone, capped | | 576/576 (100 %) | 0 diff (100 %id) |
BX648092 | human testis | .c | 501 to 5793 | 1 to 5293 | | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) | 5293/5293 (100 %) | 8 diff (99.9 %id) |
DB088352 | testis | .d | 1 to 533 | 3 to 535 | exact | tiling clone, capped | | 534/534 (100 %) | 0 diff (100 %id) |
CD656809 | Embryonic Stem cells | .e-u | 1 to 820 | 11 to 829 | exact | tiling clone, | | 819/829 (98 %) | 5 diff (99.4 %id) |
AA977579 | pooled | .f | 1 to 478 | 477 to 2 | exact | tiling clone, | | 476/480 (99 %) | 3 diff (99.4 %id) |
AA421364 | | .g | 1 to 434 | 1 to 433 | S67A C68V D69T C70A V71* | tiling clone, | | 433/433 (100 %) | 2 diff (99.6 %id) |
CR984436 | T-Lymphocytes | .h-u | 1 to 223 | 2 to 226 | A2X R20S A21G G22W A23C ... | tiling clone, | | 226/235 (96 %) | 4 diff (98.3 %id) |
AA279703 | germinal center B cell | Gene FBXO34, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AA279787 | germinal center B cell | Gene FBXO34, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
BM451989 | eye, retinoblastoma | Gene FBXO34, variant not shown | | | | | This clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h-u |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes CI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !